In The News

Take Surge Pricing to the Limit. Then Go Further.

October 9, 2015 | The New York Times

The New York Times’ John Schwartz asks Eric Dezenhall about why Martin Shkreli the Turing Pharmaceutical executive who raised its drug Daraprim price to $750 a pill from $13.50 was vilified so quickly. Read the article for Eric’s simple answer.


Eric Dezenhall at the Newseum

July 17, 2015

This July Eric Dezenhall spoke at the Newseum in Washington, D.C. With former Assistant Secretary of Defense Torie Clark about handling online attacks on brand and personal reputations.  Sign up below to receive updates from Eric Dezenhall regarding speaking engagements and…Read More


Our CEO - Eric Dezenhall    Learn More

Eric co-founded Dezenhall Resources, Ltd. in 1987 and today serves as the company's CEO. Prior to starting the firm, Eric worked at an international public relations agency and a political consulting firm. Today, he is a frequent guest commentator on national public affairs programs and is widely quoted in leading news publications. Eric was named one of Business Insider's 25 most influential PR People Behind the Scenes of Corporate America. Please watch this video of Eric discussing the "Fiasco Vortex", a theme he explores in his recent publication GLASS JAW.

There when you need us    Learn More

When an insignificant story becomes a cause célèbre, we get the call. Before a stock plummets, sponsors bolt, or a digital age posse shows up with a rope, we get the call. Dezenhall Resources, Ltd. is the nation’s leading, high-stakes, crisis-management firm based in Washington, D.C. We know how hostile attention affects the news cycle and public opinion, and how public opinion can affect your personal status or marketplace. When everything that really matters is at stake, we get the call.